MARGARITA CHAVEZ

Profile

First Name

: MARGARITA

Middle Name

:

Last Name

: CHAVEZ

Related Companies
Titles
Company Name
Related People
DIRECTOR
CARMA THERAPEUTICS INC.
JACOB GUNTERBERG, MICHAEL HEFFERNAN, REGINA HODITS, STEVEN KELLY, HY LEVITSKY, DORA MITCHELL, BRIGGS MORRISON, ERAN NADAV, BRUCE PEACOCK, MICHAEL POISEL, ALTHEA STILLMAN, CHIDOZIE UGWUMBA
DIRECTOR
CARISMA THERAPEUTICS INC.
JACOB GUNTERBERG, MICHAEL HEFFERNAN, REGINA HODITS, STEVEN KELLY, HY LEVITSKY, DORA MITCHELL, BRIGGS MORRISON, ERAN NADAV, BRUCE PEACOCK, MICHAEL POISEL, ALTHEA STILLMAN, CHIDOZIE UGWUMBA
DIRECTOR
MAGNOLIA NEUROSCIENCES CORP
MICHAEL BARAN, BARBARA DALTON, M. JOHNSTON ERWIN, STEVE GILLIS, IAN HOWES, THONG LE, ALICE LY, JOEL MARCUS, KENDALL MOHLER, DAVID SCHUBERT, ASISH XAVIER
DIRECTOR
RODEO THERAPEUTICS CORP
STEVE GILLIS, KATIE HEWITT, IAN HOWES, THONG LE, JOEL MARCUS, SANFORD MARKOWITZ, KENDALL MOHLER, LINDSAY RAYLE, SUZANNE RETTENMIER, DAVID SCHUBERT, JAMES SULLIVAN, ASISH XAVIER, TADATAKA YAMADA
DIRECTOR
NITROME BIOSCIENCES, INC
JONATHAN BEHR, IRENE GRISWOLD-PRENNER, ZACH HALL, ZACH W. HALL, EPHRAIM HELLER, EPHREIM HELLER, REGIS KELLY, WILLIAM MCDOWELL, HENRIJETTE RICHTER
DIRECTOR
AMBAGON THERAPEUTICS INC.
MICHELLE ARKIN, LUCAS BRUNSVELD, ROEL BULTHUIS, SCOTT CLARKE, PETER DUDEK, MELISSA MCCRACKEN, BRYAN MILLER, JANWILLEM NAESENS, CHRISTIAN OTTMANN, NANCY PRYER, ADAM ROSENBERG, JOSH SEIDENFELD
DIRECTOR
SNC THERAPEUTICS, INC.
JEFFREY A. HUBBELL, EVAN A. SCOTT
DIRECTOR
ALIGOS THERAPEUTICS, INC.
HARDEAN ACHNECK, LEONID BEIGELMAN, LAWRENCE BLATT, LAWRENCE M. BLATT, LESLEY ANN CALHOUN, SUSHMITA CHANDA, BRIAN DOWD, JOHN FRY, KATHLEEN GLAUB, K. PETER HIRTH, PETER HIRTH, BRIDGET MARTELL, MATTHEW MCCLURE, PETER MOLDT, CAROLE NEUCHTERLEIN, JACK NIELSEN, CAROLE NUECHTERLEIN, HEATHER PRESTON, LUCINDA QUAN, JAMES SCOPA, JULIAN SYMONS, TOM WOIWODE, MICHAEL YI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-28
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-02-11 
2023-03-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-22 
2022-06-01
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-05 
2022-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-05 
2021-12-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-07 
2021-08-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-30 
2021-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-22 
2020-08-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-17 
2020-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-07 
2020-07-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-26 
2020-04-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-04-08 
2020-04-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-26 
2019-07-09
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-26 
2019-03-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-26 
2018-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-03 
2018-07-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-26 
2018-04-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-31 
2017-06-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-31